International Orthopaedics

, Volume 42, Issue 5, pp 1183–1190 | Cite as

Effects of human parathyroid hormone 1–34 on bone loss and lumbar intervertebral disc degeneration in ovariectomized rats

  • Yang Luo
  • Shu-yang Li
  • Fa-ming Tian
  • Hui-ping Song
  • Ying-ze Zhang
  • Liu Zhang
Original Paper
  • 87 Downloads

Abstract

Purpose

Lumbar intervertebral disc degeneration is a common cause of lower back pain that affects the physical and mental health of patients and increases social burden. Parathyroid hormone has been reported to be effective at inhibiting disc degeneration; however, these effects have not been fully established in vivo in ovariectomized (OVX) rats. Thus, in this study, we aimed to address this issue and examine the effects of parathyroid hormone treatment in OVX rats.

Methods

Thirty female Sprague-Dawley rats, three months-old, were subjected to sham or ovariectomy surgery. Twelve weeks postsurgery, OVX rats were treated with either human parathyroid hormone [hPTH(1–34), 30 μg/kg/day] or vehicle (normal saline (NS)) treatment. The L3–6 spinal segments were harvested after 12 weeks treatment. Bone mineral density (BMD), micro-architectural parameters, and biomechanical assessment were measured at the lumbar vertebral bodies. Histology and immunohistochemistry were performed to analyze the characteristics of the lumbar intervertebral discs.

Results

OVX + PTH rats had significantly higher BMD, percentage bone volume density, trabecular thickness, and biomechanical strength compared with those in Sham and OVX + NS rats. Histology and immunostaining revealed that disc degeneration was not significantly different between the OVX + NS rats and the OVX + PTH rats, compared with the Sham group; the structure of nucleus pulposus was disordered, the expression of collagen I was increased, and collagen II and aggrecan were decreased.

Conclusions

These findings confirmed that hPTH(1–34) treatment has substantial anabolic effects on bone mass and trabecular micro-architecture, while the excessively enhanced bone mass and strength were coupled with a non-significant effect on the disc degeneration in ovariectomized rats.

Keywords

Osteoporosis Parathyroid hormone Bone mineral density Bone biomechanics, ovariectomy 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that there they have no conflict of interest.

Ethical approval

All experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee.

References

  1. 1.
    Mwale F, Masuda K, Pichika R et al (2011) The efficacy of Link N as a mediator of repair in a rabbit model of intervertebral disc degeneration. Arthritis Res Ther 13:R120CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Boden SD, Davis DO, Dina TS et al (1990) Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am 72:403–408CrossRefPubMedGoogle Scholar
  3. 3.
    Jackson RD, Mysiw WJ (2014) Insights into the epidemiology of postmenopausal osteoporosis: the Women’s Health Initiative. Semin Reprod Med 32:454–462CrossRefPubMedGoogle Scholar
  4. 4.
    Baccaro LF, Conde DM, Costa-Paiva L et al (2015) The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging 10:583–591CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Nanjo Y, Morio Y, Nagashima H et al (2003) Correlation between bone mineral density and intervertebral disk degeneration in pre- and postmenopausal women. J Bone Miner Metab 21:22–22CrossRefPubMedGoogle Scholar
  6. 6.
    Fabreguet I, Fechtenbaum J, Briot K et al (2013) Lumbar disc degeneration in osteoporotic men: prevalence and assessment of the relation with presence of vertebral fracture. J Rheumatol 40:1183–1190CrossRefPubMedGoogle Scholar
  7. 7.
    Wang YX, Griffith JF (2010) Effect of menopause on lumbar disc degeneration: potential etiology. Radiology 257:318–320CrossRefPubMedGoogle Scholar
  8. 8.
    Wang T, Zhang L, Huang C et al (2004) Relationship between osteopenia and lumbar intervertebral disc degeneration in ovariectomized rats. Calcif Tissue Int 75:205–213CrossRefPubMedGoogle Scholar
  9. 9.
    Luo Y, Zhang L, Wang WY et al (2013) Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats. Bone 55:439–448CrossRefPubMedGoogle Scholar
  10. 10.
    Tian FM, Yang K, Wang WY et al (2015) Calcitonin suppresses intervertebral disk degeneration and preserves lumbar vertebral bone mineral density and bone strength in ovariectomized rats. Osteoporos Int 26:2853–2861CrossRefPubMedGoogle Scholar
  11. 11.
    Poynton AR, Lane JM (2002) Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976) 27:S40–S48CrossRefGoogle Scholar
  12. 12.
    Madiraju P, Gawri R, Wang H et al (2013) Mechanism of parathyroid hormone-mediated suppression of calcification markers in human intervertebral disc cells. Eur Cell Mater 25:268–283CrossRefPubMedGoogle Scholar
  13. 13.
    Shen V, Birchman R, Wu DD et al (2000) Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion. J Bone Miner Res 15:740–746CrossRefPubMedGoogle Scholar
  14. 14.
    Zhou H, Shen V, Dempster DW et al (2001) Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res 16:1300–1307CrossRefPubMedGoogle Scholar
  15. 15.
    Lyritis GP, Georgoulas T, Zafeiris CP (2010) Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis. Ann N Y Acad Sci 1205:277–283CrossRefPubMedGoogle Scholar
  16. 16.
    Jiang Y, Zhao JJ, Mitlak BH et al (2003) Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18(11):1932–1941CrossRefPubMedGoogle Scholar
  17. 17.
    Dempster DW, Cosman F, Kurland ES et al (2001) Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846–1853CrossRefPubMedGoogle Scholar
  18. 18.
    Kang R, Li H, Ringgaard S et al (2014) Interference in the endplate nutritional pathway causes intervertebral disc degeneration in an immature porcine model. Int Orthop 38:1011–1077CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Shen Y, Li M, Wronski TJ (1997) Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats. Calcif Tissue Int 60:457–461CrossRefPubMedGoogle Scholar
  20. 20.
    Chung SA, Wei AQ, Connor DE et al (2007) Nucleus pulposus cellular longevity by telomerase gene therapy. Spine (Phila Pa 1976) 32:1188–1196CrossRefGoogle Scholar
  21. 21.
    Griffith JF, Yeung DK, Antonio GE et al (2005) Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 236:945–951CrossRefPubMedGoogle Scholar
  22. 22.
    Griffith JF, Yeung DK, Tsang PH et al (2008) Compromised bone marrow perfusion in osteoporosis. J Bone Miner Res 23:1068–1075CrossRefPubMedGoogle Scholar
  23. 23.
    Wang YX, Griffith JF, Ma HT et al (2011) Relationship between gender, bone mineral density, and disc degeneration in the lumbar spine: a study in elderly subjects using an eight-level MRI-based disc degeneration grading system. Osteoporos Int 22:91–96CrossRefPubMedGoogle Scholar
  24. 24.
    Wang Y, Boyd SK, Battié MC et al (2011) Is greater lumbar vertebral BMD associated with more disk degeneration? A study using μCT and discography. J Bone Miner Res 26:2785–2791CrossRefPubMedGoogle Scholar
  25. 25.
    Zhou Z, Tian FM, Gou Y et al (2016) Enhancement of lumbar fusion and alleviation of adjacent segment disc degeneration by intermittent PTH(1-34) in ovariectomized rats. J Bone Miner Res 31:828–838CrossRefPubMedGoogle Scholar
  26. 26.
    Sztrolovics R, Alini M, Roughley PJ et al (1997) Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem J 326:235–241CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Li D, Yang H, Huang Y et al (2014) Lumbar intervertebral disc puncture under C-arm fluoroscopy: a new rat model of lumbar intervertebral disc degeneration. Exp Anim 63:227–234CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Park JS, Park JB, Park IJ et al (2014) Accelerated premature stress-induced senescence of young annulus fibrosus cells of rats by high glucose-induced oxidative stress. Int Orthop 38:1311–1320CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Than KD, Rahman SU, Wang L et al (2014) Intradiscal injection of simvastatin results in radiologic, histologic, and genetic evidence of disc regeneration in a rat model of degenerative disc disease. Spine J 14:1017–1028CrossRefPubMedGoogle Scholar
  30. 30.
    Liang CZ, Li H, Tao YQ et al (2013) Dual release of dexamethasone and TGF-beta3 from polymeric microspheres for stem cell matrix accumulation in a rat disc degeneration model. Acta Biomater 9:9423–9233CrossRefPubMedGoogle Scholar
  31. 31.
    Yang F, Leung VY, Luk KD et al (2009) Injury-induced sequential transformation of notochordal nucleus pulposus to chondrogenic and fibrocartilaginous phenotype in the mouse. J Pathol 218:113–121CrossRefPubMedGoogle Scholar
  32. 32.
    Hou Y, Shi G, Shi J et al (2016) Study design: in vitro and in vivo assessment of bone morphogenic protein 2 combined with platelet-rich plasma on treatment of disc degeneration. Int Orthop 40:1143–1155CrossRefPubMedGoogle Scholar

Copyright information

© SICOT aisbl 2018

Authors and Affiliations

  • Yang Luo
    • 1
    • 2
  • Shu-yang Li
    • 3
  • Fa-ming Tian
    • 4
  • Hui-ping Song
    • 1
  • Ying-ze Zhang
    • 2
  • Liu Zhang
    • 1
  1. 1.Department of Orthopedic SurgeryAffiliated Hospital of North China University of Science and TechnologyTangshanPeople’s Republic of China
  2. 2.Department of Orthopedic SurgeryThe Third Hospital of Hebei Medical UniversityShijiazhuangPeople’s Republic of China
  3. 3.College of Traditional Chinese MedicineInner Mongolia Medical UniversityHuhehaotePeople’s Republic of China
  4. 4.Medical Research CenterNorth China University of Science and TechnologyTangshanPeople’s Republic of China

Personalised recommendations